Microbiome‐Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease

Reuben S. Maghembe, Donath Damian, Samweli Bahati, Abdalah Makaranga

Open source

DOI
10.1096/fba.2026-00201
Published
2026-10
Container
FASEB BioAdvances
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1096/fba.2026-00201,
  title = {Microbiome‐Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease},
  author = {Reuben S. Maghembe and Donath Damian and Samweli Bahati and Abdalah Makaranga},
  year = {2026},
  journal = {FASEB BioAdvances},
  doi = {10.1096/fba.2026-00201},
  url = {https://doi.org/10.1096/fba.2026-00201}
}

RIS

TY  - JOUR
TI  - Microbiome‐Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease
AU  - Reuben S. Maghembe
AU  - Donath Damian
AU  - Samweli Bahati
AU  - Abdalah Makaranga
PY  - 2026
JO  - FASEB BioAdvances
DO  - 10.1096/fba.2026-00201
UR  - https://doi.org/10.1096/fba.2026-00201
ER  - 

APA

Maghembe, R. S., Damian, D., Bahati, S., & Makaranga, A. (2026). Microbiome‐Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease. FASEB BioAdvances. https://doi.org/10.1096/fba.2026-00201

Source records